The efficacy of cognitive behavioural therapy in treating selective mutism in young children aged 4 to 10 years old: a qualitative systematic review
The present systematic review evaluates the quality of evidence of empirical studies about the efficacy of cognitive behavioural therapy (CBT) and combination therapy (psychopharmacotherapy) in the treatment of selective mutism in young children aged 4–10 years old. Of the 223 studies returned in...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/168509 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | The present systematic review evaluates the quality of evidence of empirical studies about the
efficacy of cognitive behavioural therapy (CBT) and combination therapy
(psychopharmacotherapy) in the treatment of selective mutism in young children aged 4–10
years old. Of the 223 studies returned in a systematic review of the literature from a ten-year
period from 2012 to 2022, only fifteen studies matched the selection criteria for the qualitative
synthesis. After evaluating these studies against preregistered quality indicators, two of fifteen
studies provided “sufficient evidence” to evaluate the efficacy of the treatment, while the other
thirteen showed “partial evidence”. From our qualitative analysis, we found that (a) diverse
implementations of CBT were effective in treating selective mutism, (b) combination therapy is
limited to fluoxetine and CBT, and (c) there are insufficient randomised controlled trials (five of
fifteen studies) to firmly conclude that CBT and combination therapy are effective interventions
for selective mutism. We highlight the limitations of existing studies and made recommendations
to improve the quality of future evidence: future research can benefit from more randomised
controlled trials with larger samples that raise the statistical validity of CBT/combination therapy
effects. Additionally, researchers should focus on the blinding of all key persons in their studies
as a safeguard against biases. |
---|